While the studies supporting these benefits were not initially focused on kidney health and included patients with low kidney risk, they suggest a link between GLP-1 RAs treatment and kidney protection, especially for type 2 diabetes patients with CKD 18
When GLP-1 receptor agonists chronically stimulate these receptors, the C-cells proliferate
Monitoring: Periodically monitor blood chemistries, vital signs, plasma carnitine concentrations, and overall clinical condition
It is now known that cellular inflammation is at the root of most diseases, including arthritis
NHS struggling to cope with overwhelming weight-loss drug demand
Previous research also demonstrated that species differences can be expected with respect to the activity of -GT enzyme in the intestinal mucosa (63)